Cargando…
Application of drug-coated balloon in coronary artery intervention: challenges and opportunities
In recent decades, the outcomes of coronary heart disease (CHD) have markedly improved, which can be partly attributed to the use of novel drugs (especially statins and antiplatelet drugs) and partly to the evolution of percutaneous coronary intervention (PCI). From percutaneous transluminal coronar...
Autores principales: | GAO, Lei, CHEN, Yun-Dai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253407/ https://www.ncbi.nlm.nih.gov/pubmed/28133467 http://dx.doi.org/10.11909/j.issn.1671-5411.2016.11.005 |
Ejemplares similares
-
Drug-Coated Balloon in Primary Percutaneous Coronary Intervention
por: Zhao, Hui, et al.
Publicado: (2023) -
What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?
por: Chen, Yun-Dai, et al.
Publicado: (2022) -
Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review
por: Mohiaddin, Hasan, et al.
Publicado: (2018) -
Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2022) -
Percutaneous Coronary Intervention in the Elderly: Are Drug-coated Balloons the Future?
por: Merinopoulos, Ioannis, et al.
Publicado: (2018)